View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Softigel
28 September 2015

Softigel by Procaps to Attend CPhI Madrid

The company will have a team of experts at stand #9C60 in hall 9.

Softigel by Procaps will be attending CPhI Worldwide in Madrid from 13-15 October.

The company will have a team of experts at stand #9C60 in hall 9, who will be able to discuss mutual opportunities.

Softigel by Procaps develops manufactures and commercialises pharmaceutical, nutritional, veterinary and cosmetics products worldwide.

The company is Latin America’s largest softgel encapsulator, with an annual capacity of 11 billion doses, plus more than 500 softgel formulations experience, and facilities approved by the FDA, MHRA and TGA.

Softigel is part of the Procaps Group, a diversified brand in charge of healthcare and related businesses, including softgel capsule manufacturing, advanced new drug delivery technologies, and a pharmaceutical division with a network distribution that reaches 48 countries worldwide.

At CPhI, Softigel seeks new OTC consumer healthcare, generic Rx and pharma customers with collaboration opportunities inside the US, other highly regulated markets or elsewhere globally.

The compan is suited to traditional softgel or advanced drug delivery technologies.

These technologies include Unigel, the only patented technology for fixed dose combinations, Versagels, a new approach to vegetarian soft capsules and Gummygels.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena